PATRICK DIAMOND: Open Payments
NPI 1912411851 · BETHEL PARK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,537 in 76 payments from 17 companies in 2025. Trend: 2023 $1,459 · 2024 $1,548 · 2025 $1,537
Food & beverage: $1,537
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $282 |
| PFIZER INC. | 15 | $280 |
| Novo Nordisk Inc | 10 | $203 |
| GlaxoSmithKline, LLC. | 9 | $183 |
| AstraZeneca Pharmaceuticals LP | 8 | $159 |
| Lilly USA, LLC | 5 | $102 |
| Exact Sciences Corporation | 2 | $55 |
| Merck Sharp & Dohme LLC | 3 | $49 |
| Abbott Laboratories | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
Products named: QULIPTA, NURTEC ODT, Wegovy, VRAYLAR, FARXIGA, TRELEGY ELLIPTA, PAXLOVID, MOUNJARO.
Industry payments across PA — which companies pay providers there.
